{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:49:32Z","timestamp":1762782572857},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s40744-021-00299-8","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T04:51:30Z","timestamp":1616302290000},"page":"751-760","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade"],"prefix":"10.1007","volume":"8","author":[{"given":"Guillermo","family":"Carvajal Alegria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divi Y. K.","family":"Cornec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Renaudineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Saraux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Devauchelle-Pensec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,21]]},"reference":[{"key":"299_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/rheumatology\/kez251","volume":"59","author":"A Mahr","year":"2020","unstructured":"Mahr A, Belhassen M, Paccalin M, Devauchelle-Pensec V, Nolin M, Gandon S, et al. Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data. Rheumatol Oxf Engl. 2020;59:120\u20138.","journal-title":"Rheumatol Oxf Engl"},{"key":"299_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","volume":"141","author":"R Caporali","year":"2004","unstructured":"Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, et al. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2004;141:493\u2013500.","journal-title":"Ann Intern Med"},{"key":"299_CR3","doi-asserted-by":"publisher","first-page":"e000694","DOI":"10.1136\/rmdopen-2018-000694","volume":"4","author":"A Floris","year":"2018","unstructured":"Floris A, Piga M, Cauli A, Salvarani C, Mathieu A. Polymyalgia rheumatica: an autoinflammatory disorder? RMD Open. 2018;4:e000694.","journal-title":"RMD Open"},{"key":"299_CR4","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/rheumatology\/kex169","volume":"56","author":"G Carvajal Alegria","year":"2017","unstructured":"Carvajal Alegria G, Devauchelle-Pensec V, Renaudineau Y, Saraux A, Pers J-O, Cornec D. Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica. Rheumatol Oxf Engl. 2017;56:1401\u20136.","journal-title":"Rheumatol Oxf Engl"},{"key":"299_CR5","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.1038\/s41598-017-06826-4","volume":"7","author":"Y van Sleen","year":"2017","unstructured":"van Sleen Y, Wang Q, van der Geest KSM, Westra J, Abdulahad WH, Heeringa P, et al. Involvement of monocyte subsets in the immunopathology of giant cell arteritis. Sci Rep. 2017;7:6553.","journal-title":"Sci Rep"},{"key":"299_CR6","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1002\/art.34647","volume":"64","author":"M Samson","year":"2012","unstructured":"Samson M, Audia S, Fraszczak J, Trad M, Ornetti P, Lakomy D, et al. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis. Arthritis Rheum. 2012;64:3788\u201398.","journal-title":"Arthritis Rheum"},{"key":"299_CR7","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/art.38625","volume":"66","author":"KSM van der Geest","year":"2014","unstructured":"van der Geest KSM, Abdulahad WH, Chalan P, Rutgers A, Horst G, Huitema MG, et al. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica. Arthritis Rheumatol Hoboken NJ. 2014;66:1927\u201338.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"299_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/annrheumdis-2011-200413","volume":"71","author":"NT Baerlecken","year":"2012","unstructured":"Baerlecken NT, Linnemann A, Gross WL, Moosig F, Vazquez-Rodriguez TR, Gonzalez-Gay MA, et al. Association of ferritin autoantibodies with giant cell arteritis\/polymyalgia rheumatica. Ann Rheum Dis. 2012;71:943\u20137.","journal-title":"Ann Rheum Dis"},{"key":"299_CR9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3389\/fimmu.2019.01981","volume":"10","author":"Y van Sleen","year":"2019","unstructured":"van Sleen Y, Graver JC, Abdulahad WH, van der Geest KSM, Boots AMH, Sandovici M, et al. Leukocyte dynamics reveal a persistent myeloid dominance in giant cell arteritis and polymyalgia rheumatica. Front Immunol. 2019;10:1981.","journal-title":"Front Immunol"},{"key":"299_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005615117","author":"X Xu","year":"2020","unstructured":"Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA. 2020. https:\/\/doi.org\/10.1073\/pnas.2005615117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"299_CR11","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1136\/annrheumdis-2015-208742","volume":"75","author":"V Devauchelle-Pensec","year":"2016","unstructured":"Devauchelle-Pensec V, Berthelot JM, Cornec D, Renaudineau Y, Marhadour T, Jousse-Joulin S, et al. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study. Ann Rheum Dis. 2016;75:1506\u201310.","journal-title":"Ann Rheum Dis"},{"key":"299_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.semarthrit.2019.12.005","volume":"50","author":"M Akiyama","year":"2020","unstructured":"Akiyama M, Kaneko Y, Takeuchi T. Tocilizumab in isolated polymyalgia rheumatica: a systematic literature review. Semin Arthritis Rheum. 2020;50:521\u20135.","journal-title":"Semin Arthritis Rheum"},{"key":"299_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jbspin.2016.07.003","volume":"83","author":"V Devauchelle-Pensec","year":"2016","unstructured":"Devauchelle-Pensec V. Has the time come for biotherapies in giant cell arteritis and polymyalgia rheumatica? Jt Bone Spine. 2016;83:471\u20132.","journal-title":"Jt Bone Spine"},{"key":"299_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3899\/jrheum.110866","volume":"39","author":"C Cleuziou","year":"2012","unstructured":"Cleuziou C, Binard A, De Bandt M, Berthelot J-M, Saraux A. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice. J Rheumatol. 2012;39:310\u20133.","journal-title":"J Rheumatol"},{"key":"299_CR15","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1002\/art.22015","volume":"54","author":"Y Renaudineau","year":"2006","unstructured":"Renaudineau Y, Croquefer S, Jousse S, Renaudineau E, Devauchelle V, Gu\u00e9guen P, et al. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum. 2006;54:2523\u201332.","journal-title":"Arthritis Rheum"},{"key":"299_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1365-2036.2011.04908.x","volume":"35","author":"K Zachou","year":"2012","unstructured":"Zachou K, Oikonomou K, Renaudineau Y, Chauveau A, Gatselis N, Youinou P, et al. Anti-\u03b1 actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1. Aliment Pharmacol Ther. 2012;35:116\u201325.","journal-title":"Aliment Pharmacol Ther"},{"key":"299_CR17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.semarthrit.2020.04.013","volume":"50","author":"G Carvajal Alegria","year":"2020","unstructured":"Carvajal Alegria G, Saraux A, Devauchelle-Pensec V. Is tocilizumab as efficient as steroids early in polymyalgia rheumatica? Semin Arthritis Rheum. 2020;50:582.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00299-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-021-00299-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00299-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T04:16:48Z","timestamp":1624249008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-021-00299-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,21]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["299"],"URL":"https:\/\/doi.org\/10.1007\/s40744-021-00299-8","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,21]]},"assertion":[{"value":"10 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}